PERSPECTA

News from every angle

Back to headlines

Novartis bets on pipeline as Big Pharma seeks growth through acquisitions

An analysis suggests that while Big Pharma companies are acquiring growth, Novartis is strategically betting on its internal drug development pipeline for future expansion.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.